Agilon Health, Inc. (NYSE:AGL) Given Average Rating of “Hold” by Analysts

Shares of Agilon Health, Inc. (NYSE:AGL) have been given an average recommendation of “Hold” by the fifteen brokerages that are currently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and five have assigned a buy rating to the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is $58.7273.

AGL has been the topic of a number of research analyst reports. Robert W. Baird increased their price objective on shares of Agilon Health from $20.00 to $35.00 and gave the stock a “neutral” rating in a research report on Thursday, May 7th. Wells Fargo & Company restated an “overweight” rating and set a $72.00 price target (up from $37.50) on shares of Agilon Health in a research note on Friday, May 8th. JPMorgan Chase & Co. downgraded shares of Agilon Health from a “neutral” rating to an “underweight” rating and set a $21.00 price objective on the stock. in a report on Monday, May 4th. TD Cowen reaffirmed a “hold” rating and issued a $55.00 price objective (up from $17.00) on shares of Agilon Health in a research note on Monday, May 11th. Finally, Jefferies Financial Group upgraded shares of Agilon Health from a “hold” rating to a “buy” rating and lifted their price objective for the company from $27.50 to $48.00 in a report on Thursday, May 7th.

Agilon Health Stock Performance

NYSE AGL opened at $110.29 on Friday. The firm’s fifty day moving average price is $82.44 and its two-hundred day moving average price is $40.09. The stock has a market cap of $1.84 billion, a PE ratio of -5.12 and a beta of 2.98. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.04 and a current ratio of 1.04. Agilon Health has a fifty-two week low of $7.48 and a fifty-two week high of $125.71.

Agilon Health (NYSE:AGL) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $1.80 EPS for the quarter, topping analysts’ consensus estimates of $1.04 by $0.76. Agilon Health had a negative net margin of 6.09% and a negative return on equity of 146.03%. The company had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.38 billion. On average, equities analysts expect that Agilon Health will post -3.5 EPS for the current fiscal year.

Institutional Trading of Agilon Health

A number of institutional investors and hedge funds have recently modified their holdings of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Agilon Health by 3.5% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 214,200 shares of the company’s stock worth $927,000 after purchasing an additional 7,209 shares in the last quarter. Dynamic Technology Lab Private Ltd raised its stake in Agilon Health by 28.4% during the first quarter. Dynamic Technology Lab Private Ltd now owns 47,111 shares of the company’s stock valued at $204,000 after buying an additional 10,424 shares during the last quarter. Apollon Wealth Management LLC boosted its holdings in Agilon Health by 17.4% in the fourth quarter. Apollon Wealth Management LLC now owns 82,348 shares of the company’s stock worth $57,000 after acquiring an additional 12,193 shares in the last quarter. Legal & General Group Plc grew its stake in shares of Agilon Health by 4.1% in the second quarter. Legal & General Group Plc now owns 346,031 shares of the company’s stock worth $796,000 after acquiring an additional 13,700 shares during the last quarter. Finally, Symphony Financial Services Inc. increased its holdings in shares of Agilon Health by 51.6% during the third quarter. Symphony Financial Services Inc. now owns 47,000 shares of the company’s stock valued at $48,000 after acquiring an additional 16,000 shares in the last quarter.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.